Clinical Trial Update: Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating whether very early and rapid cholesterol lowering with evolocumab improves left ventricular remodeling after anterior …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Henan Institute of Cardiovascular Epidemiology | Conditions: ST Elevation Myocardial Infarction (STEMI) | Phase 4 | Status: RECRUITING